Zofran is a medication that blocks nausea and vomiting signals sent to the brain. Many women have been prescribed the drug Zofran to treat morning sickness. Unfortunately what these expecting mothers were NEVER TOLD –

  • Zofran is FDA approved only to treat nausea in chemotherapy patients.
  • The FDA never approved Zofran for use in pregnant women; it has been used “off label” to treat morning sickness and nausea during pregnancy.
  • In January 2012, the CDC published a report that showed a link between women who took Zofran during their first trimester and serious birth defects.
  • According to a 2013 medical study, Zofran doubled the risk of heart defects, and increased by 30% the risk of other birth defects including heart murmur, hole in the heart, cleft lip, cleft palate, and other serious health risks.

Zofran Lawsuit Information

In February 2015, a lawsuit was filed against GlaxoSmithKline by a woman from Massachusetts. After taking Zofran her child was born with severe birth defects requiring several corrective surgeries. Since this lawsuit has been filed many mothers are now recognizing the detrimental effects Zofran could have had on their children and they are taking legal action. If you were prescribed Zofran while pregnant and you experienced premature labor or your child was born with a birth defect you deserve financial compensation for medical expenses, lost wages and emotional trauma. Don’t wait any longer! Call our office today! At the Bryant Law Center we offer the “No Fee Promise”, you don’t pay anything until we settle your case. Call today or fill out our online form, we look forward to helping you!


January 1991 FDA approves Zofran for the use in cancer patients taking chemotherapy to reduce nausea and vomiting
March 2006 It is found that OB/GYNS are the most frequent prescribers of Zofran, using it to treat pregnant women for morning sickness. This research was gathered by the FDA.
January 2012 The CDC publishes a report showing that women who took Zofran during the first trimester double the risk of their baby being born with birth defects.
July 2012 GlaxoSmithKline pleads guilty and is forced to pay 3 billion after the federal government accuses them of marketing and misrepresenting several drugs. Zofran was one of these drugs -marketed as a treatment for morning sickness in pregnant women WITHOUT FDA APPROVAL.
January 2015 2 lawsuits are filed against the makers of Zofran, GlaxoSmithKline. Both women had taken Zofran during their first trimester and their babies were born with serious heart defects.